[EN] TREATMENT OF ENERGY UTILIZATION DISEASES<br/>[FR] TRAITEMENT DE MALADIES UTILISANT DE L'ÉNERGIE
申请人:SUMMIT CORP PLC
公开号:WO2010049678A2
公开(公告)日:2010-05-06
Described are various compounds, in particular iminosugars, for the treatment of energy utilization diseases, in particular diabetes (including type 1 diabetes, type 2 diabetes and insulin resistance) and metabolic syndrome (including any disease or disorder associated therewith, for example central obesity and elevated levels of triglycerides).